|
VidexDrug - Videx The trade name of the product as shown on the labeling.
Dosage -
FOR SOLUTION; ORAL
Active Ingredient(s) -
Didanosine
Strength -
375MG/PACKET
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
020155
Product Number -
006
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 9, 1991
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Myers Squibb Co Pharmaceutical Research Institute
Videx
Videx Ec 250mg Capsule, Delayed Rel Pellets; Oral
Videx Ec 400mg Capsule, Delayed Rel Pellets; Oral Videx 100mg/packet For Solution; Oral Videx 10mg/ml For Solution; Oral Videx 167mg/packet For Solution; Oral Videx 250mg/packet For Solution; Oral Videx 375mg/packet For Solution; Oral Didanosine 400mg Capsule, Delayed Rel Pellets; Oral Videx Ec 125mg Capsule, Delayed Rel Pellets; Oral Videx Ec 200mg Capsule, Delayed Rel Pellets; Oral NewDrugInformation |